The Relevance Between the Level of Fetal Hemoglobin and Short-term Complications in Extremely Preterm Infants
NCT ID: NCT05788562
Last Updated: 2023-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
92 participants
OBSERVATIONAL
2023-04-01
2024-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.
NCT04802629
Long Term Health Cohort of Premature Infants
NCT05017389
a Clinical Risk Score to Predict Bloody Stool in Neonates
NCT05055817
Transfusions and Nitric Oxide Level in Preterm Infants
NCT00787124
The Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants
NCT01762189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Incorporate blood gas analysis indicators in D1-D7, after birth,1 week before and on the day of onset of early complications
No interventions assigned to this group
Control group
Incorporate blood gas analysis indicators in D1-D7,D14,D28after birth and the day of diacharge
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Parents agree to attend
Exclusion Criteria
2. severe congenital deformity
3. parents reject to attend
1 Day
2 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Hospital of Jilin University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First hospital of Jilin University
Changchun, Jilin, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
wu hui
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.